ambossIconambossIcon

Lichen planus

Last updated: December 2, 2024

Summarytoggle arrow icon

Lichen planus is a chronic inflammatory disease characterized by lesions involving the skin (i.e., cutaneous), mucosa (i.e., mucosal), and hair or nails (i.e., appendageal). It most commonly affects adults aged 30–60 years. The exact etiology is unknown. Cutaneous lichen planus typically manifests as pruritic purple papules and plaques with well-demarcated irregular borders and Wickham striae on the extremities (e.g., wrists and ankles). Mucosal lichen planus manifestations include papules, plaques, Wickham striae, and erosions on the oral, esophageal, and/or genital mucosa. Diagnosis is based on the presence of clinical features or typical histology; biopsy should be performed if the diagnosis is uncertain. Screening for hepatitis C should be considered for all patients. Early specialist consult is required for mucosal lichen planus and hypertrophic cutaneous lichen planus because of the risk of treatment resistance and the potential for malignant transformation to squamous cell carcinoma (SCC). First-line treatment consists of high-potency topical steroids; intralesional preparations are indicated for hypertrophic cutaneous disease and appendageal involvement.

Icon of a lock

Register or log in , in order to read the full article.

Epidemiologytoggle arrow icon

  • Prevalence: rare disease (occurs in < 1% of the population) [1][2]
  • Age of onset: 30–60 years [3]
  • Sex [1]

Epidemiological data refers to the US, unless otherwise specified.

Icon of a lock

Register or log in , in order to read the full article.

Etiologytoggle arrow icon

Although the exact etiology of lichen planus is unknown, possible etiologic factors include:

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

Lichen planus is categorized based on the areas of involvement: cutaneous, mucosal, and appendageal. The most common cutaneous and mucosal manifestations are presented here. Additional manifestations are described in “Subtypes and variants.” [1]

Cutaneous lichen planus [2][7]

  • 6 Ps of cutaneous lichen planus
    • Purple (violaceous)
    • Polygonal, irregular borders
    • Planar (flat-topped)
    • Pruritic, often severe
    • Papules
    • Plaques
  • Wickham striae: white reticular lines on the surface of the lesions
  • Bilateral, symmetrical involvement of the extremities (e.g., ankles, flexor wrists) and, in some cases, the trunk
  • See also hypertrophic cutaneous lichen planus in “Subtypes and variants.”

The 6 Ps of cutaneous lichen Planus: Purple, Polygonal, Planar (flat-topped), Pruritic, Papules, and Plaques Postinflammatory hypopigmentation and postinflammatory hyperpigmentation may be present. [1]

Mucosal lichen planus [2][7]

See “Subtypes and variants” for information on esophageal lichen planus.

Icon of a lock

Register or log in , in order to read the full article.

Subtypes and variantstoggle arrow icon

Hypertrophic cutaneous lichen planus [2][7]

Esophageal lichen planus [7]

Appendegeal lichen planus [7]

Lichen planopilaris [7]

Nail lichen planus [7]

Icon of a lock

Register or log in , in order to read the full article.

Diagnosistoggle arrow icon

Lichen planus is a clinical diagnosis. Diagnostic studies are indicated in patients with atypical, extensive, or refractory lesions. [2][7]

Perform a history and physical examination to assess all potential areas of involvement (i.e., cutaneous, mucosal, appendageal). [7]

Icon of a lock

Register or log in , in order to read the full article.

Pathologytoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Differential diagnosestoggle arrow icon

Chronic graft-versus-host disease can manifest with cutaneous and mucosal lesions that resemble lichen planus. [15]

The differential diagnoses listed here are not exhaustive.

Icon of a lock

Register or log in , in order to read the full article.

Treatmenttoggle arrow icon

Cutaneous lichen planus (non-hypertrophic) [1][2][7]

Topical calcineurin inhibitors are associated with a theoretical risk of malignancy and must be used with caution, particularly in mucosal and hypertrophic cutaneous lichen planus. [8]

Hypertrophic or noncutaneous lichen planus [1][2][7][8]

Refer to appropriate specialists (e.g., dermatology, oral surgery, urology, gynecology) for management and long-term monitoring for complications (e.g., scarring, SCC). [7][8][10]

Treatment is generally not indicated for asymptomatic mucosal lichen planus; reserve treatment for symptomatic flares (e.g., painful erosions). [8]

Mucosal, hypertrophic cutaneous, and appendageal lichen planus are associated with malignant transformation to squamous cell carcinoma. [7]

Icon of a lock

Register or log in , in order to read the full article.

Prognosistoggle arrow icon

Any localization of erosive lichen planus can cause scarring, which may lead to functional limitations.

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer